Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 334
interventional 189
Observational 122
Registry 23

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 71
Device 33
Other 19
Drug|placebo 17
Procedure 13
Behavioral 7
Device|Drug 7
Diagnostic Test 6
Drug|Other 3
Biological 2
Device|Other 2
Device|Procedure 2
Behavioral|Other 1
Biological|Device 1
Combination Product|Procedure 1
Diagnostic Test|Drug 1
Drug|Procedure 1
Genetic 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 57
France 18
China 9
Canada 8
NA 8
Netherlands 7
Spain 6
Denmark 5
Switzerland 5
Italy 4
Japan 4
United States|Canada 3
Germany 2
Sweden 2
United Kingdom 2
Australia|Austria|Brazil|Germany|Hungary|Israel|Italy|Netherlands|South Africa 1
Australia|Germany|Mexico|Spain|United Kingdom 1
Australia|New Zealand 1
Austria 1
Belgium 1
Belgium|France|Netherlands|Spain|Switzerland 1
Brazil 1
Brazil|United States|Argentina|Australia|Austria|Belgium|Canada|Chile|Colombia|Czech Republic|Denmark|France|Germany|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|Norway|Peru|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Canada|Netherlands|Switzerland 1
Canada|New Zealand 1
Canada|United States|Australia|Austria|Belgium|Brazil|Czech Republic|Denmark|Finland|France|Germany|Italy|Netherlands|New Zealand|Norway|Poland|South Africa|Spain|Sweden|United Kingdom 1
China|United States|Andorra|Australia|Austria|Belgium|Brazil|Canada|Czech Republic|Denmark|Estonia|Finland|France|Germany|Hong Kong|Hungary|India|Indonesia|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Netherlands|New Zealand|Norway|Philippines|Poland|Puerto Rico|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
Colombia 1
Colombia|Austria|Belgium|Brazil|Chile|China|Czech Republic|Denmark|France|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Norway|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Ukraine|United Kingdom 1
Czechia 1
Egypt 1
Finland 1
France|Netherlands|Switzerland 1
France|Spain 1
France|Switzerland 1
Germany|Switzerland 1
Hong Kong 1
Iraq 1
Israel 1
Netherlands|United States|Belgium|Canada|France|Ireland|Norway|Russian Federation|Spain 1
Nigeria 1
Norway 1
Russian Federation 1
Turkey 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czech Republic|Denmark|Egypt|Estonia|France|Greece|India|Israel|Italy|Mexico|Netherlands|Norway|Peru|Philippines|Poland|Portugal|Puerto Rico|Russian Federation|Slovakia|South Africa|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Brazil|Canada|Chile|China|Czechia|Denmark|Estonia|France|Germany|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czech Republic|Denmark|Finland|France|Germany|Italy|Netherlands|Norway|Poland|Spain|Sweden|Switzerland|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|China|Czech Republic|Denmark|France|Germany|Hong Kong|Hungary|India|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Singapore|South Africa|Spain|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|Czech Republic|Denmark|France|Germany|Hong Kong|India|Israel|Italy|Korea, Republic of|Mexico|Norway|Philippines|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Singapore|South Africa|Spain|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|China|Denmark|France|Germany|Hungary|India|Israel|Mexico|Norway|Poland|Romania|Russian Federation|Spain|Sweden|Ukraine|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada|Denmark|Hungary|Israel|Mexico|Poland|Russian Federation|Sweden|Turkey 1
United States|Argentina|Australia|Canada|Denmark|Israel|Mexico|Poland|Puerto Rico 1
United States|Argentina|Brazil|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|El Salvador|France|Germany|Guatemala|Hungary|India|Israel|Kenya|Korea, Republic of|Lebanon|Malaysia|Netherlands|Norway|Panama|Portugal|Russian Federation|Serbia|Singapore|Slovenia|Spain|Taiwan|Thailand|Turkey|Ukraine 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Czech Republic|Denmark|Finland|France|Germany|Hong Kong|Hungary|India|Indonesia|Israel|Italy|Korea, Republic of|Malaysia|Netherlands|New Zealand|Norway|Philippines|Poland|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Russian Federation|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|United Kingdom|Vietnam 1
United States|Australia|Brazil|Canada|India|Israel|Latvia|Lithuania|Poland|Russian Federation|South Africa|Ukraine|United Kingdom 1
United States|Australia|United Kingdom 1
United States|Austria|Belgium|France|Germany|Italy|Netherlands|Spain 1
United States|Austria|Greece|Israel|South Africa|United Kingdom 1
United States|Belgium|Chile 1
United States|Belgium|France|Hungary|Italy|Netherlands 1
United States|Belgium|France|Switzerland 1
United States|Canada|Ireland|United Kingdom 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 91
2 13
3 6
4 8
5 2
6 1
7 2
8 5
9 4
10 2
11 2
12 1
13 2
14 3
16 1
17 2
18 2
19 2
20 3
21 2
22 4
23 2
27 1
28 2
30 2
31 3
38 1
39 1
46 1
50 1
65 1
70 1
93 1
101 1
107 1
122 1
139 1
143 1
148 1
151 1
267 1
297 1
305 1
322 1
382 1
429 1
454 1

Phase

Phase Study_Count
N/A 84
Phase 3 36
Phase 4 36
Phase 2 14
Phase 1 9
Early Phase 1 5
Phase 2/Phase 3 3
Phase 1/Phase 2 2

Number of Arms

Number_of_Arms Count_of_Studies
1 49
2 96
3 12
4 3
5 1
6 1
8 1
NA 26

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 20.0 10.0000 8.00000 102 10.0000 306.0 17.000 5.000
1st Qu. 20.0 78.5000 22.00000 110 34.2500 390.5 99.250 101.500
Median 20.0 200.0000 40.00000 118 69.5000 475.0 372.000 175.000
Mean 74.8 843.2169 54.77778 118 146.7143 673.0 1652.324 1083.917
3rd Qu. 116.0 725.0000 90.00000 126 125.0000 856.5 3079.250 585.750
Max. 198.0 19652.0000 118.00000 134 961.0000 1238.0 8292.000 20000.000

Trial Group Type

group_type Group_Count
Experimental 155
Active Comparator 92
No Intervention 27
NA 26
Other 19
Placebo Comparator 14
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 113
Single Group Assignment 61
Crossover Assignment 8
NA 4
Factorial Assignment 2
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 83
Prevention 44
Diagnostic 35
Other 6
Screening 6
NA 6
Basic Science 4
Health Services Research 3
Supportive Care 2

Observational Studies

Studies by Country

Country Study_Count
United States 22
France 18
NA 17
Italy 6
Germany 5
China 4
Spain 4
Canada 3
Netherlands 3
Sweden 3
Turkey 3
United Kingdom 3
Argentina 2
Denmark 2
Algeria|Egypt|Indonesia|Jordan|Kazakhstan|Kenya|Korea, Republic of|Kuwait|Lebanon|Malaysia|Mexico|Morocco|Philippines|Qatar|Russian Federation|Saudi Arabia|Singapore|Taiwan|Turkey|Ukraine|United Arab Emirates 1
Australia 1
Australia|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
Belgium|France|Guadeloupe 1
Belgium|France|Switzerland 1
Benin|Burkina Faso|Burundi|Cameroon|Congo, The Democratic Republic of the|Congo|Côte D’Ivoire|Gabon|Guinea|Mozambique|Niger|Senegal|Sudan 1
Canada|France|Switzerland 1
Canada|Netherlands|Switzerland 1
Egypt 1
France|Italy|Mexico|Netherlands 1
France|Switzerland 1
Greece 1
Ireland 1
Italy|Spain 1
Korea, Republic of 1
Mexico 1
Norway 1
Poland 1
Russian Federation 1
Switzerland 1
Taiwan 1
United States|Austria|Canada|France|Germany|Italy|Netherlands|Spain 1
United States|Belgium|France|Italy|Spain 1
United States|Canada 1
United States|Canada|France|Italy|Spain 1
United States|Puerto Rico 1
United States|Saudi Arabia 1

Sites per Study

Site_count Study_Count
1 85
2 5
3 3
4 4
5 2
6 1
7 3
8 1
9 5
10 1
11 1
15 1
18 1
20 3
21 1
23 1
26 1
46 1
53 1
231 1

Enrollment Metrics

Measure Observational
Min 15.00
1st Qu 188.00
Median 444.00
Mean 22730.36
3rd Qu 1378.00
Max 665533.00

Observation Model

observational_model Study_Count
Cohort 88
Case-Only 8
Case Control 7
Case-Control 6
Other 6
NA 6
Case-Crossover 1

Time Perspective

time_perspective Study_Count
Prospective 89
Retrospective 20
Cross-Sectional 6
Other 5
NA 2

Registries

Studies by Country

Country Study_Count
United States 5
China 4
NA 3
Poland 2
Belgium|France 1
Belgium|Netherlands|Poland 1
Brazil 1
France 1
Italy 1
Russian Federation 1
Switzerland 1
United Kingdom 1
United States|Austria|France|Germany|Netherlands|Switzerland|Turkey|United Kingdom 1

Sites per Study

Site_count Study_Count
1 13
2 3
5 1
6 1
8 1
9 1
12 1
80 1
209 1

Enrollment Metrics

Measure Registries
Min 15.00
1st Qu 462.00
Median 1500.00
Mean 46071.48
3rd Qu 5000.00
Max 902891.00

Registry Model

observational_model Study_Count
Cohort 19
Other 3
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 20
Other 3

Follow-up

target_duration Study_Count
5 Years 4
1 Year 3
3 Years 3
30 Days 3
3 Months 2
1 Day 1
1 Month 1
10 Months 1
12 Months 1
12 Weeks 1
2 Years 1
24 Months 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04263038 Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04263038 Recruiting University Hospital Inselspital, Berne 2024-02-29
NCT03966079 Thrombolysis Endovascular Treatment of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03966079 Completed Beijing Tsinghua Chang Gung Hospital 2020-01-31
NCT03405480 Pulmonary Rehabilitation to Improve Physical Capacity After Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03405480 Recruiting Ostfold Hospital Trust 2020-06-01
NCT03389971 ULTRAsound-assisted Catheter vs. STAndaRd Catheter Thrombolysis for Submassive Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03389971 Active, not recruiting Piedmont Healthcare 2021-02-01
NCT03375723 Effects of Information and Breathing Technique - for Patients With Respiratory Pain in Acute Pulmonary Embolism. https://ClinicalTrials.gov/show/NCT03375723 Recruiting Göteborg University 2021-12-31
NCT04294849 Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis https://ClinicalTrials.gov/show/NCT04294849 Recruiting University of Texas Southwestern Medical Center 2022-12-31
NCT03339349 Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma https://ClinicalTrials.gov/show/NCT03339349 Completed University of Utah 2019-06-30
NCT03274401 Screening for Atrial Fibrillation in Pulmonary Embolism Study -SAFE-PE Study https://ClinicalTrials.gov/show/NCT03274401 Recruiting Danderyd Hospital 2022-09-11
NCT03218566 Evaluating the Safety and Efficacy of the Indigo® Aspiration System in Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03218566 Completed Penumbra Inc. 2019-03-10
NCT03218410 Surgical Pulmonary Embolectomy Versus Catheter-directed Thrombolysis in the Treatment of Pulmonary Embolism: A Non-inferiority Study https://ClinicalTrials.gov/show/NCT03218410 Recruiting University Hospital Inselspital, Berne 2020-06-30
NCT03212365 Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery https://ClinicalTrials.gov/show/NCT03212365 Completed University of Utah 2019-06-02
NCT03197792 Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary Endarterectomy https://ClinicalTrials.gov/show/NCT03197792 Recruiting Centre Chirurgical Marie Lannelongue 2018-05-24
NCT03185845 The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism https://ClinicalTrials.gov/show/NCT03185845 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-12-31
NCT03183063 Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events https://ClinicalTrials.gov/show/NCT03183063 Completed William Beaumont Hospitals 2019-04-23
NCT03173066 Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography https://ClinicalTrials.gov/show/NCT03173066 Enrolling by invitation Brigham and Women’s Hospital 2020-05-31
NCT03129555 The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) https://ClinicalTrials.gov/show/NCT03129555 Recruiting Danish Heart Foundation 2020-03-31
NCT03116139 Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT https://ClinicalTrials.gov/show/NCT03116139 Recruiting Indiana University 2021-12-31
NCT03086317 Standard vs Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03086317 Active, not recruiting Emory University 2020-12-08
NCT03070834 RIPT Feasibility Trial https://ClinicalTrials.gov/show/NCT03070834 Recruiting Lawson Health Research Institute 2020-02-16
NCT03023605 Analysis of a Training Intervention for Pulmonary Embolism Diagnosis in Emergency Department (APEED) https://ClinicalTrials.gov/show/NCT03023605 Completed Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau 2017-11-30
NCT03002467 Impact Analysis of Prognostic Stratification for Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03002467 Recruiting Università degli Studi dell’Insubria 2019-09-30
NCT02970032 Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin https://ClinicalTrials.gov/show/NCT02970032 Completed University of Utah 2017-09-10
NCT02923115 Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02923115 Completed Daiichi Sankyo, Inc. 2019-07-05
NCT02890706 Iodine Mapping Using Subtraction in Pulmonary Embolism CT Versus Dual-Energy CT https://ClinicalTrials.gov/show/NCT02890706 Completed Radboud University 2017-10-30
NCT02811237 Hospitalization or Out-treatment ManagEment of Patients With Pulmonary Embolism: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02811237 Completed University Hospital, Angers 2019-07-31
NCT02810704 Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement https://ClinicalTrials.gov/show/NCT02810704 Active, not recruiting Dartmouth-Hitchcock Medical Center 2022-08-31
NCT02798471 Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) https://ClinicalTrials.gov/show/NCT02798471 Recruiting Daiichi Sankyo, Inc. 2020-12-31
NCT02774265 A Different Approach to Preventing Thrombosis https://ClinicalTrials.gov/show/NCT02774265 Completed University of Maryland, Baltimore 2017-05-31
NCT02758574 Standard vs. Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02758574 Recruiting University of Pittsburgh 2020-07-31
NCT02744092 Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer https://ClinicalTrials.gov/show/NCT02744092 Active, not recruiting Alliance Foundation Trials, LLC. 2020-06-30
NCT02733198 Prognostication in Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02733198 Completed Ministry of Health, Spain 2019-11-30
NCT02704052 Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose https://ClinicalTrials.gov/show/NCT02704052 Completed University of Utah 2018-07-31
NCT02692586 FlowTriever Pulmonary Embolectomy Clinical Study https://ClinicalTrials.gov/show/NCT02692586 Completed Inari Medical 2017-11-30
NCT02687204 Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients https://ClinicalTrials.gov/show/NCT02687204 Completed University of Utah 2017-06-23
NCT02684721 Does a Home-based Exercise Programme Affect Physical Capacity and Quality of Life in Patients With Pulmonary Embolism? https://ClinicalTrials.gov/show/NCT02684721 Completed Central Jutland Regional Hospital 2018-09-01
NCT02616991 Computed Tomography CT Venography During Postpartum Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02616991 Recruiting Assistance Publique - Hôpitaux de Paris 2020-03-31
NCT02600260 Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial https://ClinicalTrials.gov/show/NCT02600260 Active, not recruiting University of Sao Paulo General Hospital 2019-07-31
NCT02585713 Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02585713 Completed Academic and Community Cancer Research United 2018-04-02
NCT02584660 A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department https://ClinicalTrials.gov/show/NCT02584660 Completed Janssen Scientific Affairs, LLC 2017-03-22
NCT03080883 Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy https://ClinicalTrials.gov/show/NCT03080883 Recruiting Academic and Community Cancer Research United 2022-05-01
NCT02483143 NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02483143 Completed Karadeniz Technical University 2015-02-28
NCT02474212 : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery https://ClinicalTrials.gov/show/NCT02474212 Recruiting Tampere University Hospital 2020-12-31
NCT02450825 Comparison of Three Scores for Ultrasound Assessment and Monitoring of Pulmonary Aeration https://ClinicalTrials.gov/show/NCT02450825 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2017-02-28
NCT02411292 Enoxaparin Metabolism in Reconstructive Surgery Patients https://ClinicalTrials.gov/show/NCT02411292 Completed University of Utah 2016-03-31
NCT02402881 Education Bundle to Decrease Patient Refusal of VTE Prophylaxis https://ClinicalTrials.gov/show/NCT02402881 Completed Johns Hopkins University 2018-11-30
NCT02396758 Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02396758 Active, not recruiting EKOS Corporation 2019-04-30
NCT02334007 Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery https://ClinicalTrials.gov/show/NCT02334007 Completed McMaster University 2018-09-30
NCT02283086 Effects of Performance Feedback on Imaging Use in the Emergency Department https://ClinicalTrials.gov/show/NCT02283086 Completed Brigham and Women’s Hospital 2013-12-31
NCT02238639 Pulmonary Embolism as a Cause of COPD Exacerbations https://ClinicalTrials.gov/show/NCT02238639 Recruiting Ministry of Health, Spain 2019-12-31
NCT02186223 The Angel® Catheter Pivotal Clinical Trial https://ClinicalTrials.gov/show/NCT02186223 Completed BiO2 Medical 2015-12-31
NCT02161965 Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation https://ClinicalTrials.gov/show/NCT02161965 Completed University Hospital, Angers 2016-12-31
NCT02132689 Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02132689 Completed University Hospital Ostrava 2015-05-31
NCT02073682 Cancer Venous Thromboembolism (VTE) https://ClinicalTrials.gov/show/NCT02073682 Completed Daiichi Sankyo, Inc. 2017-09-15
NCT02070237 Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis https://ClinicalTrials.gov/show/NCT02070237 Completed MemorialCare Health System 2014-03-31
NCT02066662 Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification https://ClinicalTrials.gov/show/NCT02066662 Active, not recruiting RWTH Aachen University 2020-03-31
NCT02064439 Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) https://ClinicalTrials.gov/show/NCT02064439 Completed Bayer 2016-09-22
NCT02059551 Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02059551 Active, not recruiting Assistance Publique - Hôpitaux de Paris 2018-11-28
NCT01305564 A Prospective, Multi-Center Study of the Bard® Denali™ Retrievable Inferior Vena Cava Filter System https://ClinicalTrials.gov/show/NCT01305564 Completed C. R. Bard 2015-06-30
NCT02046096 Cook IVC Filter Study https://ClinicalTrials.gov/show/NCT02046096 Completed Cook Group Incorporated 2018-12-18
NCT02035293 Frequency of Diagnostic Symptomatic Pulmonary Embolism’s in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) https://ClinicalTrials.gov/show/NCT02035293 Completed University Hospital, Brest 2017-10-13
NCT01975090 The SENTRY Clinical Study https://ClinicalTrials.gov/show/NCT01975090 Completed Novate Medical 2016-08-31
NCT01939301 Nitric Oxide to Treat Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01939301 Completed Indiana University 2016-10-31
NCT01898637 A Simple Clinical Tool to Help Diagnose Pulmonary Embolism: Phase 1 https://ClinicalTrials.gov/show/NCT01898637 Enrolling by invitation Mayo Clinic 2020-06-30
NCT01828697 Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy https://ClinicalTrials.gov/show/NCT01828697 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2020-12-31
NCT01797289 Prevalence of Pulmonary Embolism in Patients With Syncope https://ClinicalTrials.gov/show/NCT01797289 Completed University of Padova 2014-10-31
NCT01780987 AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients https://ClinicalTrials.gov/show/NCT01780987 Completed Pfizer 2014-09-30
NCT01752673 The Visualization of Uncertainty in Clinical Diagnostic Reasoning for Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01752673 Completed University of Calgary 2011-10-31
NCT01729559 Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin https://ClinicalTrials.gov/show/NCT01729559 Completed Scripps Health 2014-09-30
NCT01630148 Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries https://ClinicalTrials.gov/show/NCT01630148 Completed Hawler Medical University 2014-03-31
NCT01613794 Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis https://ClinicalTrials.gov/show/NCT01613794 Completed Leiden University Medical Center 2016-12-31
NCT01542762 Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation https://ClinicalTrials.gov/show/NCT01542762 Completed Leiden University Medical Center 2016-07-31
NCT01516814 Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients https://ClinicalTrials.gov/show/NCT01516814 Completed Bayer 2013-10-31
NCT01513759 Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy https://ClinicalTrials.gov/show/NCT01513759 Completed EKOS Corporation 2013-02-17
NCT01403090 Safety Study of the Angelâ„¢ Catheter in Subjects With Risk of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01403090 Completed BiO2 Medical 2012-03-31
NCT01326507 Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01326507 Completed University Hospital, Toulouse 2011-06-30
NCT04410549 Pulmonary Optical Coherence Tomography in COVID-19 Patients https://ClinicalTrials.gov/show/NCT04410549 Recruiting IRCCS San Raffaele 2020-06-30
NCT04318782 A Prospective Study for the Treatment of Severe Pulmonary Embolism With Pharmacodynamic Thrombectomy https://ClinicalTrials.gov/show/NCT04318782 Recruiting Assistance Publique - Hôpitaux de Paris 2021-02-10
NCT04283240 Sildenafil in Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04283240 Completed University of Aarhus 2017-09-10
NCT04099186 Hydro-mechanical Defragmentation of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04099186 Recruiting Assiut University 2020-09-01
NCT04088292 Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04088292 Recruiting Rigshospitalet, Denmark 2021-06-05
NCT04047784 Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients https://ClinicalTrials.gov/show/NCT04047784 Enrolling by invitation University of California, Los Angeles 2021-06-01
NCT04032769 Modified Strategy to Safely Rule Out Pulmonary Embolism in the Emergency Department https://ClinicalTrials.gov/show/NCT04032769 Recruiting Assistance Publique - Hôpitaux de Paris 2020-06-30
NCT04022915 PET Fibrin Imaging of DVT and PE https://ClinicalTrials.gov/show/NCT04022915 Recruiting Massachusetts General Hospital 2023-05-13
NCT04003116 Air Versus Oxygen for Intermediate-Risk Pulmonary Embolism (AIRE) https://ClinicalTrials.gov/show/NCT04003116 Recruiting Ministry of Health, Spain 2021-03-31
NCT03999905 Impact of Pharmacists’ Training on Oral Anticoagulant Counseling https://ClinicalTrials.gov/show/NCT03999905 Completed University of Ibadan 2019-09-30
NCT03927508 First - In - Man Study to Assess the Safety and Feasibility of The Bashirâ„¢ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03927508 Active, not recruiting Thrombolex, Inc. 2019-12-03
NCT03886194 Thrombolytic and Interventional Treatment of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03886194 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2020-12-31
NCT03862755 Chemoprophylaxis Plus Early Ambulation https://ClinicalTrials.gov/show/NCT03862755 Completed Shanghai Pulmonary Hospital, Shanghai, China 2017-09-12
NCT03854266 Low Dose Catheter Directed Thrombolysis for Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03854266 Recruiting University of Aarhus 2023-03-10
NCT03795740 Pulmonary Endarterectomy Guided by CT Scanning for Patients With Chronic Thromboembolic Pulmonary Hypertension—-PEACT https://ClinicalTrials.gov/show/NCT03795740 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-05-31
NCT03729544 Computerized Decision Support to Increase Detection of Chronic Thromboembolic Pulmonary Hypertension in Patients With Prior Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03729544 Recruiting Brigham and Women’s Hospital 2021-01-30
NCT03719027 Prevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH) https://ClinicalTrials.gov/show/NCT03719027 Recruiting Assistance Publique - Hôpitaux de Paris 2020-12-31
NCT03682419 Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL) https://ClinicalTrials.gov/show/NCT03682419 Completed LumiraDx UK Limited 2018-11-23
NCT03601676 Electronic Support for Pulmonary Embolism Emergency Disposition https://ClinicalTrials.gov/show/NCT03601676 Completed Kaiser Permanente 2016-04-30
NCT03581877 Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE https://ClinicalTrials.gov/show/NCT03581877 Recruiting Northwell Health 2021-12-31
NCT03579849 Pulmonary Perfusion by Iodine Subtraction Mapping CT Angiography in Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03579849 Completed University Hospital, Brest 2019-04-24
NCT03573492 Bedside Ultrasound in the Assessment of Deep Venous Thrombosis: Effectiveness of In-Person Versus Online Instruction https://ClinicalTrials.gov/show/NCT03573492 Completed Mercy Health Ohio 2018-12-05
NCT03516656 Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin https://ClinicalTrials.gov/show/NCT03516656 Active, not recruiting University of Utah 2019-06-30
NCT03487237 Prevalence of PE in ED Patients With Isolated Syncope https://ClinicalTrials.gov/show/NCT03487237 Completed Assistance Publique - Hôpitaux de Paris 2018-12-18
NCT03438123 Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera https://ClinicalTrials.gov/show/NCT03438123 Completed Spectrum Dynamics 2019-10-15
NCT01258140 Detection of Pulmonary Embolism With Low-dose CT Pulmonary Angiography https://ClinicalTrials.gov/show/NCT01258140 Completed University Hospital Inselspital, Berne 2012-12-31
NCT01166997 ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism https://ClinicalTrials.gov/show/NCT01166997 Completed EKOS Corporation 2013-04-30
NCT01134068 Age-adjusted D-dimer Cut-off Levels to Rule Out Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01134068 Completed University Hospital, Geneva 2013-07-31
NCT01120535 Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter 4 https://ClinicalTrials.gov/show/NCT01120535 Completed Crux Biomedical 2011-06-30
NCT01120522 Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 3 (“RETRIEVE 3”) https://ClinicalTrials.gov/show/NCT01120522 Completed Crux Biomedical 2011-06-30
NCT01120509 Crux Biomedical Vena Cava Filter Study - United States https://ClinicalTrials.gov/show/NCT01120509 Completed Crux Biomedical 2011-06-30
NCT01112917 VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial https://ClinicalTrials.gov/show/NCT01112917 Completed B. Braun Interventional Systems, Inc 2015-09-30
NCT01104337 Drug Interaction Between Paracetamol and Warfarin https://ClinicalTrials.gov/show/NCT01104337 Completed Hopital Lariboisière 2008-11-30
NCT01059500 Assessment of Acute Disease to Reduce Imaging Costs https://ClinicalTrials.gov/show/NCT01059500 Completed Atrium Health 2012-05-31
NCT00986154 Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). https://ClinicalTrials.gov/show/NCT00986154 Completed Daiichi Sankyo, Inc. 2013-04-30
NCT00981409 The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients https://ClinicalTrials.gov/show/NCT00981409 Completed GlaxoSmithKline 2008-12-31
NCT00968929 Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC) https://ClinicalTrials.gov/show/NCT00968929 Completed Beijing Chao Yang Hospital 2009-05-31
NCT00967148 Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer https://ClinicalTrials.gov/show/NCT00967148 Completed Ottawa Hospital Research Institute 2010-09-30
NCT00904293 Genotype-Guided Warfarin Therapy Trial https://ClinicalTrials.gov/show/NCT00904293 Completed University of North Carolina, Chapel Hill 2012-01-31
NCT00894283 Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients https://ClinicalTrials.gov/show/NCT00894283 Completed Johns Hopkins University 2013-09-30
NCT00853463 Discharge ALERT: Quality Improvement Initiative https://ClinicalTrials.gov/show/NCT00853463 Completed Brigham and Women’s Hospital 2010-03-31
NCT00848731 Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00848731 Completed Atrium Health 2011-05-31
NCT03240120 A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03240120 Recruiting The University of Hong Kong 2021-05-31
NCT04393909 Improving Safety of Diagnosis and Therapy in the Inpatient Setting https://ClinicalTrials.gov/show/NCT04393909 Recruiting Brigham and Women’s Hospital 2021-06-30
NCT03953560 Symptom-related Screening for Early Detection of CTEPH. https://ClinicalTrials.gov/show/NCT03953560 Recruiting Hospitales Universitarios Virgen del Rocío 2019-12-31
NCT02983760 Comparison of 3 Diagnostic Strategies of PE: Planar V/Q Scan, CTPA, and V/Q SPECT. https://ClinicalTrials.gov/show/NCT02983760 Recruiting University Hospital, Brest 2022-07-10
NCT02476526 Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease https://ClinicalTrials.gov/show/NCT02476526 Completed VA Greater Los Angeles Healthcare System 2017-11-20
NCT01542723 Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy https://ClinicalTrials.gov/show/NCT01542723 Completed Leiden University Medical Center 2016-07-31
NCT02946944 Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02946944 Recruiting Meshalkin Research Institute of Pathology of Circulation 2020-10-31
NCT02375919 PERC Rule to Exclude Pulmonary Embolism in the Emergency Deparment https://ClinicalTrials.gov/show/NCT02375919 Completed Assistance Publique - Hôpitaux de Paris 2017-04-30
NCT04373707 Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 https://ClinicalTrials.gov/show/NCT04373707 Recruiting Central Hospital, Nancy, France 2020-09-30
NCT00786422 Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer https://ClinicalTrials.gov/show/NCT00786422 Completed Bayer 2011-05-31
NCT00781378 Low Dosage of rt-PA in the Treatment of Pulmonary Thromboembolism in China https://ClinicalTrials.gov/show/NCT00781378 Completed Beijing Chao Yang Hospital 2006-02-28
NCT00780767 Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00780767 Completed University Hospital, Geneva 2011-10-31
NCT00773448 Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00773448 Completed Ottawa Hospital Research Institute 2015-04-30
NCT00740883 Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. “PADIS-PE” Study. https://ClinicalTrials.gov/show/NCT00740883 Completed University Hospital, Brest 2015-10-31
NCT00720915 D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months https://ClinicalTrials.gov/show/NCT00720915 Completed McMaster University 2016-12-31
NCT00711308 Tinzaparin in the Treatment of the Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00711308 Completed Complejo Hospitalario Xeral-Calde 2009-01-31
NCT00654979 A Pivotal Study to Evaluate the Safety and Effectiveness of RMT Medical Technology’s SafeFlo® Vena Cava Filter https://ClinicalTrials.gov/show/NCT00654979 Completed RMT Medical Technologies, Ltd. 2008-03-31
NCT00643201 Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00643201 Completed Bristol-Myers Squibb 2013-03-31
NCT00633893 Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00633893 Completed Bristol-Myers Squibb 2012-08-31
NCT00605332 Crux Biomedical IVC Filter - Evaluation of the Crux Inferior Vena Cava Filter System (Retrieve) https://ClinicalTrials.gov/show/NCT00605332 Completed Crux Biomedical 2008-07-31
NCT00603317 Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid https://ClinicalTrials.gov/show/NCT00603317 Completed Assistance Publique - Hôpitaux de Paris 2010-03-31
NCT00586287 Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon https://ClinicalTrials.gov/show/NCT00586287 Completed Cantonal Hospital of St. Gallen 2011-12-31
NCT00565253 Inhaled Nitric Oxide in Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00565253 Completed Medical University of Vienna 2009-07-31
NCT00556426 Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. https://ClinicalTrials.gov/show/NCT00556426 Completed C. R. Bard 2007-04-30
NCT00799968 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China https://ClinicalTrials.gov/show/NCT00799968 Completed Beijing Chao Yang Hospital 2006-02-28
NCT00519506 A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli https://ClinicalTrials.gov/show/NCT00519506 Completed Agen Biomedical 2008-06-30
NCT00511173 Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm https://ClinicalTrials.gov/show/NCT00511173 Completed Creighton University 2008-11-30
NCT00488865 RexMedical- Option* Vena Cava Filter IDE Study https://ClinicalTrials.gov/show/NCT00488865 Completed Rex Medical 2008-12-31
NCT00470626 Celect Vena Cava Filter Clinical Trial https://ClinicalTrials.gov/show/NCT00470626 Completed Cook Group Incorporated 2009-03-31
NCT00457158 PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption https://ClinicalTrials.gov/show/NCT00457158 Completed Centre Hospitalier Universitaire de Saint Etienne 2012-11-30
NCT00457002 Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness https://ClinicalTrials.gov/show/NCT00457002 Completed Bristol-Myers Squibb 2011-05-31
NCT00455819 Home Treatment of Patients With Pulmonary Embolism Based on Pro-Brain Natriuretic Peptide (BNP) Levels https://ClinicalTrials.gov/show/NCT00455819 Completed St. Antonius Hospital 2009-03-31
NCT00452530 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00452530 Completed Bristol-Myers Squibb 2009-01-31
NCT00442234 Post-marketing Study of Monteplase (“Cleactor”) in Patients With Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00442234 Completed Eisai Inc. 2008-04-01
NCT00439777 Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study https://ClinicalTrials.gov/show/NCT00439777 Completed Bayer 2011-09-30
NCT00439725 Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study https://ClinicalTrials.gov/show/NCT00439725 Completed Bayer 2009-08-31
NCT00436787 Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers https://ClinicalTrials.gov/show/NCT00436787 Completed University of Pittsburgh NA
NCT00425542 Safety Study of Outpatient Treatment for Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00425542 Completed University of Lausanne Hospitals 2010-06-30
NCT00423319 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) https://ClinicalTrials.gov/show/NCT00423319 Completed Bristol-Myers Squibb 2009-09-30
NCT00413504 Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00413504 Completed Brigham and Women’s Hospital NA
NCT00413374 Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00413374 Completed Brigham and Women’s Hospital 2008-04-30
NCT01014156 Epoprostenol in Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01014156 Completed Free University Medical Center 2006-06-30
NCT00401414 Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information https://ClinicalTrials.gov/show/NCT00401414 Completed Brigham and Women’s Hospital 2011-06-30
NCT00381511 Deferment of Imaging for Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00381511 Completed Azienda Ospedaliera Universitaria Policlinico NA
NCT00371683 Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00371683 Completed Bristol-Myers Squibb 2008-05-31
NCT00368836 Breath Analysis Technique to Diagnose Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00368836 Completed National Heart, Lung, and Blood Institute (NHLBI) 2008-04-30
NCT00365950 3 Months’ Versus 6 Months’ Anticoagulation in Patients With DVT and/or PE https://ClinicalTrials.gov/show/NCT00365950 Completed British Thoracic Society NA
NCT00358735 Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH) https://ClinicalTrials.gov/show/NCT00358735 Completed Medical Compression Systems 2008-09-30
NCT00351754 Detection of Pulmonary Embolism With CECT https://ClinicalTrials.gov/show/NCT00351754 Completed Bracco Diagnostics, Inc NA
NCT00345618 Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach https://ClinicalTrials.gov/show/NCT00345618 Completed Sanofi 2010-10-31
NCT00334464 A Pharmacogenetic Study of Warfarin Dosing, “The COUMA-GEN Study” https://ClinicalTrials.gov/show/NCT00334464 Completed Intermountain Health Care, Inc. NA
NCT00320255 A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer https://ClinicalTrials.gov/show/NCT00320255 Completed Bristol-Myers Squibb 2009-01-31
NCT00314990 VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis https://ClinicalTrials.gov/show/NCT00314990 Completed Radboud University NA
NCT00264277 D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00264277 Completed St. Orsola Hospital 2004-12-31
NCT00244725 Odiparcil For The Prevention Of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00244725 Completed GlaxoSmithKline 2006-09-30
NCT00233740 Protection From Pulmonary Embolism With the Permanent OptEaseâ„¢ Filter (PROOF) https://ClinicalTrials.gov/show/NCT00233740 Completed Cordis Corporation NA
NCT00206830 SHORTness of Breath In the Emergency Department (SHORTIE) https://ClinicalTrials.gov/show/NCT00206830 Completed Biosite 2006-08-31
NCT00196118 Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter https://ClinicalTrials.gov/show/NCT00196118 Completed Cook Group Incorporated NA
NCT00191724 Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study https://ClinicalTrials.gov/show/NCT00191724 Completed Eli Lilly and Company 2008-01-31
NCT00188032 Strategies for Suspected Pulmonary Embolism in Emergency Departments https://ClinicalTrials.gov/show/NCT00188032 Completed University Hospital, Angers NA
NCT00187408 The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial https://ClinicalTrials.gov/show/NCT00187408 Completed Sunnybrook Health Sciences Centre NA
NCT00182403 Fixed Dose Heparin Study https://ClinicalTrials.gov/show/NCT00182403 Completed McMaster University NA
NCT00182221 Safety of a Diagnostic Strategy With D-Dimer Testing for PE https://ClinicalTrials.gov/show/NCT00182221 Completed McMaster University 2008-02-29
NCT00162435 Genetic Determinants of Warfarin Anticoagulation Effect https://ClinicalTrials.gov/show/NCT00162435 Recruiting Hadassah Medical Organization 2020-12-31
NCT00117169 Multi-Detector Spiral Computed Tomography Alone Versus Combined Strategy With Lower Limb Compression Ultrasonography in Outpatients Suspected of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00117169 Completed University Hospital, Geneva NA
NCT00114608 Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot https://ClinicalTrials.gov/show/NCT00114608 Completed University at Buffalo 2007-07-31
NCT00097357 BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery https://ClinicalTrials.gov/show/NCT00097357 Completed Bristol-Myers Squibb 2005-12-31
NCT00071279 SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis https://ClinicalTrials.gov/show/NCT00071279 Completed Sanofi 2005-12-31
NCT00062803 SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00062803 Completed Sanofi 2005-10-31
NCT00796692 Nadroparin for the Initial Treatment of Pulmonary Thromboembolism https://ClinicalTrials.gov/show/NCT00796692 Completed Beijing Chao Yang Hospital 2006-02-28
NCT00007085 Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II) https://ClinicalTrials.gov/show/NCT00007085 Completed National Heart, Lung, and Blood Institute (NHLBI) 2004-12-31
NCT00000566 Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) https://ClinicalTrials.gov/show/NCT00000566 Completed National Heart, Lung, and Blood Institute (NHLBI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04420312 Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms https://ClinicalTrials.gov/show/NCT04420312 Completed Groupe Hospitalier Paris Saint Joseph 2020-04-20
NCT03275610 Genetic Markers of Patients With History of Pulmonary Embolism Post Total Joint Arthroplasty https://ClinicalTrials.gov/show/NCT03275610 Enrolling by invitation University of Southern California 2020-04-23
NCT03271450 The DARE Warfarin CER Study https://ClinicalTrials.gov/show/NCT03271450 Enrolling by invitation Brigham and Women’s Hospital 2021-04-15
NCT03231449 A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa https://ClinicalTrials.gov/show/NCT03231449 Active, not recruiting Cardiologie et Développement 2020-12-31
NCT03141749 Venous Thromboembolism in DM1 https://ClinicalTrials.gov/show/NCT03141749 Completed Institut de Myologie, France 2014-11-30
NCT03134898 Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension https://ClinicalTrials.gov/show/NCT03134898 Recruiting Sociedad Española de Neumología y Cirugía Torácica 2019-06-30
NCT03134820 Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease https://ClinicalTrials.gov/show/NCT03134820 Completed Delos Clinical 2016-12-31
NCT03124654 Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC) https://ClinicalTrials.gov/show/NCT03124654 Completed University Hospital, Basel, Switzerland 2017-07-30
NCT03114618 A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient https://ClinicalTrials.gov/show/NCT03114618 Completed Hospital General Universitario Gregorio Marañon 2016-11-30
NCT02977013 Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02977013 Completed Al Mouwasat Hospital 2016-09-30
NCT02961439 Validation of Epworth Richmond’s Echocardiography Education Focused Year https://ClinicalTrials.gov/show/NCT02961439 Completed Epworth Healthcare 2017-05-01
NCT02884934 Six Years of Follow-up After Idiopathic Venous Throbmoembolism https://ClinicalTrials.gov/show/NCT02884934 Recruiting University Hospital, Brest 2022-11-30
NCT02883491 Pulmonary Embolism Short-term Clinical Outcomes Registry https://ClinicalTrials.gov/show/NCT02883491 Recruiting Atrium Health 2020-03-31
NCT02742623 A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer https://ClinicalTrials.gov/show/NCT02742623 Completed Bayer 2018-11-30
NCT02709174 Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models https://ClinicalTrials.gov/show/NCT02709174 Completed Advocate Health Care 2015-08-31
NCT02611115 Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography. https://ClinicalTrials.gov/show/NCT02611115 Completed Maastricht University Medical Center 2016-12-31
NCT02601846 Age-adjusted D-dimer Cut-off to Rule Out Pulmonary Embolism in the Emergency Department : A Real Life Impact Study https://ClinicalTrials.gov/show/NCT02601846 Recruiting University Hospital, Geneva 2018-12-31
NCT02597218 Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study. https://ClinicalTrials.gov/show/NCT02597218 Recruiting Hospital Italiano de Buenos Aires 2019-10-31
NCT02523937 Evaluation of Soluble Fibrin in Thrombosis Exclusion https://ClinicalTrials.gov/show/NCT02523937 Completed Diagnostica Stago R&D 2018-05-31
NCT02502396 Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center https://ClinicalTrials.gov/show/NCT02502396 Active, not recruiting M.D. Anderson Cancer Center 2020-09-30
NCT02476721 Characteristics of Patients With Missed Pulmonary Embolism in the ED: A Three Year Experience https://ClinicalTrials.gov/show/NCT02476721 Completed University Hospital, Basel, Switzerland 2015-03-31
NCT02468102 Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden) https://ClinicalTrials.gov/show/NCT02468102 Active, not recruiting Bayer 2018-12-31
NCT02438462 Soluble Fibrin for Diagnosing Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02438462 Completed Diagnostica Stago R&D 2017-06-30
NCT02388841 Thrombus Localization and Accompaying Disorders and Risk Factors https://ClinicalTrials.gov/show/NCT02388841 Completed Yuzuncu Yıl University 2014-08-31
NCT02381509 Predicting the Safety and Effectiveness of Inferior Vena Cava Filters https://ClinicalTrials.gov/show/NCT02381509 Active, not recruiting HealthCore-NERI 2019-03-31
NCT02360943 Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE https://ClinicalTrials.gov/show/NCT02360943 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2021-06-30
NCT02355548 Outpatient Treatment of Low-risk Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02355548 Completed Intermountain Health Care, Inc. 2017-12-31
NCT02345356 A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics https://ClinicalTrials.gov/show/NCT02345356 Active, not recruiting University of Puerto Rico 2020-07-31
NCT02345343 Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico https://ClinicalTrials.gov/show/NCT02345343 Completed Bristol-Myers Squibb 2015-10-07
NCT02297373 Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) https://ClinicalTrials.gov/show/NCT02297373 Active, not recruiting Ottawa Hospital Research Institute 2019-01-03
NCT02258958 Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection https://ClinicalTrials.gov/show/NCT02258958 Completed McMaster University 2014-12-31
NCT02210819 Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy https://ClinicalTrials.gov/show/NCT02210819 Completed Bayer 2016-11-03
NCT02190110 Pulmonary Embolism Diagnosis: Ultrasound Wells Score vs Traditional Wells Score https://ClinicalTrials.gov/show/NCT02190110 Completed Azienda Ospedaliero-Universitaria Careggi 2015-07-31
NCT02156401 VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE https://ClinicalTrials.gov/show/NCT02156401 Recruiting Johannes Gutenberg University Mainz 2023-07-31
NCT02107001 Lung Ultrasound in Pleuritic Chest Pain https://ClinicalTrials.gov/show/NCT02107001 Completed University of Milan 2015-11-30
NCT02097602 Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery https://ClinicalTrials.gov/show/NCT02097602 Completed Technische Universität München 2014-09-30
NCT02095925 Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02095925 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2016-06-30
NCT01297348 Study Of Lybrel In Relation To Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01297348 Completed Pfizer 2012-04-30
NCT01272453 Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique https://ClinicalTrials.gov/show/NCT01272453 Completed William Beaumont Hospitals 2013-10-31
NCT04454554 Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS) https://ClinicalTrials.gov/show/NCT04454554 Recruiting Arianna Anticoagulazione Foundation 2020-09-24
NCT04413825 Early Systolic Notch in Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04413825 Recruiting Gazi University 2021-01-15
NCT01947998 Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK) https://ClinicalTrials.gov/show/NCT01947998 Completed Bayer 2018-12-31
NCT01947985 Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands) https://ClinicalTrials.gov/show/NCT01947985 Completed Bayer 2018-12-31
NCT01947959 Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany) https://ClinicalTrials.gov/show/NCT01947959 Completed Bayer 2018-12-31
NCT01908231 Prognostic Value of Plasma Lactate Levels Among Patients With Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01908231 Completed Azienda Ospedaliero-Universitaria Careggi 2014-01-31
NCT01857050 Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins https://ClinicalTrials.gov/show/NCT01857050 Completed Meir Medical Center 2014-01-31
NCT01839266 Prognostic Factors for Acute Pulmonary Embolism in Critically Ill Patients https://ClinicalTrials.gov/show/NCT01839266 Completed Yonsei University 2012-12-31
NCT01815996 Identify Clinical Conditions That Increase Circulating DNA Levels https://ClinicalTrials.gov/show/NCT01815996 Completed University of Florida 2016-07-28
NCT01781858 Study on the Clinical Course Of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01781858 Completed University of Padova 2014-05-31
NCT01736826 Free DNA and Nucleosome Concentrations in Pathological Pregnancies https://ClinicalTrials.gov/show/NCT01736826 Completed Centre Hospitalier Universitaire de Nīmes 2018-12-17
NCT01727427 Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients https://ClinicalTrials.gov/show/NCT01727427 Completed G. d’Annunzio University 2017-12-31
NCT01635257 Accuracy of Multi-organ Ultrasound for the Diagnosis of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01635257 Completed Azienda Ospedaliero-Universitaria Careggi 2012-12-31
NCT01633671 NT-proBNP as a Tool for the Detection of Acute Pulmonary Artery Embolism (APE) https://ClinicalTrials.gov/show/NCT01633671 Completed University of Ulm 2011-12-31
NCT01602445 Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01602445 Completed Ottawa Hospital Research Institute 2016-10-31
NCT01602432 Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients https://ClinicalTrials.gov/show/NCT01602432 Completed Ottawa Hospital Research Institute 2013-08-31
NCT01580085 Obstructive Sleep Apnea in Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01580085 Completed University of Gaziantep 2010-12-31
NCT01559883 Study on Thrombosis Therapy in German Cancer Patients https://ClinicalTrials.gov/show/NCT01559883 Completed LEO Pharma 2013-12-31
NCT01524393 Risk of Pulmonary and Venous Thromboembolism in Pregnancies After in Vitro Fertilization https://ClinicalTrials.gov/show/NCT01524393 Completed Danderyd Hospital 2008-12-31
NCT01457963 Prevalence of Pulmonary Embolism in ICU https://ClinicalTrials.gov/show/NCT01457963 Completed University Hospital, Grenoble 2011-04-30
NCT01455818 A Study to Evaluate the Safety of Withholding Anticoagulation in Patients With Subsegmental PE Who Have a Negative Serial Bilateral Lower Extremity Ultrasound https://ClinicalTrials.gov/show/NCT01455818 Recruiting Ottawa Hospital Research Institute 2021-12-31
NCT01372514 Institutional Registry of Thromboembolic Disease https://ClinicalTrials.gov/show/NCT01372514 Recruiting Hospital Italiano de Buenos Aires 2020-01-31
NCT04419194 Effect of Climatic Factors on the Seasonal Fluctuation of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04419194 Completed Peking Union Medical College Hospital 2019-07-31
NCT04411888 Pulmonary Embolism Prognosis Model https://ClinicalTrials.gov/show/NCT04411888 Recruiting Peking Union Medical College Hospital 2023-06-01
NCT04405869 Thromboembolic Events in Severe COVID-19 Patients https://ClinicalTrials.gov/show/NCT04405869 Recruiting University Hospital, Strasbourg, France 2021-04-30
NCT04400877 Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic https://ClinicalTrials.gov/show/NCT04400877 Recruiting University Hospital, Linkoeping 2020-06-19
NCT04374617 Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 https://ClinicalTrials.gov/show/NCT04374617 Completed Hospital Universitari Vall d’Hebron Research Institute 2020-04-25
NCT04330170 Inferior Vena Cava Filters: Analysis of a Database https://ClinicalTrials.gov/show/NCT04330170 Completed Pirogov Russian National Research Medical University 2020-03-28
NCT03410706 Xarelto for Real Life Anticoagulation in Pulmonary Embolism (PE) in China https://ClinicalTrials.gov/show/NCT03410706 Recruiting Bayer 2023-01-30
NCT04179487 The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety Study https://ClinicalTrials.gov/show/NCT04179487 Recruiting University College Dublin 2023-12-31
NCT04118634 A Regietry Study on Biomarkers of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04118634 Recruiting Beijing Institute of Heart, Lung and Blood Vessel Diseases 2020-08-31
NCT04018014 Low-dose CT Angiography in the Detection of Acute Pulmonary Embolism: Validation in an Obese Population https://ClinicalTrials.gov/show/NCT04018014 Recruiting University Hospital, Clermont-Ferrand 2019-09-30
NCT04010760 Non-invasive Diagnosis of Pulmonary Embolism by Use of Biomarkers in Exhaled Breath Condensate https://ClinicalTrials.gov/show/NCT04010760 Recruiting Aalborg University Hospital 2020-12-31
NCT03935178 Evaluating Right Ventricular (RV) Size and Function Using the Upper Valley RV Algorithm and Novel Imaging Modalities https://ClinicalTrials.gov/show/NCT03935178 Recruiting Dartmouth-Hitchcock Medical Center 2020-06-30
NCT03915925 Short-term Clinical Deterioration After Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03915925 Recruiting Atrium Health 2021-08-31
NCT03894878 Association Between Genetic Variant Scores and Warfarin Effect https://ClinicalTrials.gov/show/NCT03894878 Recruiting Cipherome, Inc. 2021-03-12
NCT03889457 What Treatment for Patients With Phlebitis or Pulmonary Embolism ? https://ClinicalTrials.gov/show/NCT03889457 Recruiting Rennes University Hospital 2021-02-12
NCT03835780 The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study https://ClinicalTrials.gov/show/NCT03835780 Completed Momentum Data 2019-08-01
NCT03754673 Role of MRI in Diagnosis of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03754673 Completed Assiut University 2020-01-01
NCT03672123 GDF-15 Levels in Risk Stratification in Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03672123 Recruiting Medical University of Warsaw 2021-01-01
NCT03657992 Time Trend Analysis of PE Diagnosis With SPECT V/Q: a Single Institution Observational Study https://ClinicalTrials.gov/show/NCT03657992 Completed University Hospital, Brest 2018-05-30
NCT03595891 The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung https://ClinicalTrials.gov/show/NCT03595891 Active, not recruiting Bristol-Myers Squibb 2018-12-28
NCT03504007 Registry of Patients Prescribed Anticoagulation https://ClinicalTrials.gov/show/NCT03504007 Recruiting Mayo Clinic 2023-03-01
NCT03477968 ThRombosis ExclUsion STudy https://ClinicalTrials.gov/show/NCT03477968 Recruiting Diagnostica Stago 2020-09-30
NCT01227317 BIOmarkers of Dyspnea IN Emergency Room https://ClinicalTrials.gov/show/NCT01227317 Completed ThermoFisher Scientific Brahms Biomarkers France 2011-08-31
NCT01221805 STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT01221805 Completed Diagnostica Stago 2016-03-31
NCT01216423 Pulmonary Embolism and Stroke in Patient With Patent Foramen Ovale https://ClinicalTrials.gov/show/NCT01216423 Completed University Hospital, Brest 2015-12-31
NCT01206751 Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation https://ClinicalTrials.gov/show/NCT01206751 Completed Taipei Medical University WanFang Hospital 2010-05-31
NCT01165892 Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar) https://ClinicalTrials.gov/show/NCT01165892 Completed Washington University School of Medicine 2013-04-30
NCT01111760 Radiation Dose From Computed Tomography Before and After Implementation of a High Pitch Dual Spiral Technique https://ClinicalTrials.gov/show/NCT01111760 Completed William Beaumont Hospitals 2012-12-31
NCT01097928 Pulmonary Embolism Response to Fragmentation, Embolectomy, & Catheter Thrombolysis: PERFECT https://ClinicalTrials.gov/show/NCT01097928 Recruiting Stanford University 2020-01-31
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity https://ClinicalTrials.gov/show/NCT01037270 Completed Biosite 2010-04-30
NCT00941187 Evolution of Pulmonary Capillary Blood Volume https://ClinicalTrials.gov/show/NCT00941187 Completed Centre Hospitalier Universitaire de Saint Etienne 2012-12-31
NCT00880737 Prognostic Value of Computed Tomography (CT) Scan in Hemodynamically Stable Patients With Acute Symptomatic Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00880737 Completed Carlos III Health Institute 2011-06-30
NCT00855231 Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain https://ClinicalTrials.gov/show/NCT00855231 Completed University of Washington 2009-07-31
NCT01183026 V/Q SPECT for Diagnosis of Pulmonary Embolism https://ClinicalTrials.gov/show/NCT01183026 Completed University Hospital, Brest NA
NCT00831259 Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO) https://ClinicalTrials.gov/show/NCT00831259 Completed University Hospital, Caen 2009-04-30
NCT03909399 Prevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients https://ClinicalTrials.gov/show/NCT03909399 Recruiting Hellenic Society of Medical Oncology 2020-01-25
NCT00805246 Assessing the Prognosis of Pulmonary Embolism Using Clinical and Imaging Biomarkers (Retrospective & Prospective ) https://ClinicalTrials.gov/show/NCT00805246 Completed University of Pittsburgh 2013-07-31
NCT02713581 IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism https://ClinicalTrials.gov/show/NCT02713581 Completed Centre Hospitalier Universitaire de Nīmes 2019-01-03
NCT03083093 CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients https://ClinicalTrials.gov/show/NCT03083093 Completed Leiden University Medical Center 2018-03-01
NCT01318174 Pulmonary Embolism in Exacerbations of Chronic Obstructive Pulmonary Disease https://ClinicalTrials.gov/show/NCT01318174 Completed Sykehuset Innlandet HF 2012-04-30
NCT01604538 Italian Pulmonary Embolism Registry - IPER https://ClinicalTrials.gov/show/NCT01604538 Completed University Of Perugia NA
NCT04335162 Cardiovascular Complications and COVID-19 (CovCardioVasc) https://ClinicalTrials.gov/show/NCT04335162 Recruiting Centre Hospitalier Universitaire de Nice 2020-08-28
NCT04373486 Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels https://ClinicalTrials.gov/show/NCT04373486 Recruiting University Hospital, Strasbourg, France 2020-04-30
NCT00816920 Natural History of Isolated Deep Vein Thrombosis of the Calf https://ClinicalTrials.gov/show/NCT00816920 Completed St. Orsola Hospital 2009-09-30
NCT00771303 Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study https://ClinicalTrials.gov/show/NCT00771303 Completed University Hospital, Geneva 2017-08-31
NCT00670540 Epidemiology of Thromboembolism Disease: A Cohort Study https://ClinicalTrials.gov/show/NCT00670540 Completed University Hospital, Grenoble 2009-01-31
NCT00660205 Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00660205 Completed University of Aarhus 2011-02-28
NCT00615147 Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population https://ClinicalTrials.gov/show/NCT00615147 Completed Memorial Sloan Kettering Cancer Center 2008-06-30
NCT00550082 3 Screen Electronic Alert https://ClinicalTrials.gov/show/NCT00550082 Completed Brigham and Women’s Hospital 2009-11-30
NCT00549705 Registry of Hospitalized Patients Treated With Fondaparinux https://ClinicalTrials.gov/show/NCT00549705 Completed Brigham and Women’s Hospital 2009-06-30
NCT00480636 Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients https://ClinicalTrials.gov/show/NCT00480636 Completed Pfizer 2009-06-30
NCT00456196 Epidemiology of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00456196 Completed Brigham and Women’s Hospital 2009-06-30
NCT00409136 Multi-Center Human Alert Trial to Prevent DVT and PE https://ClinicalTrials.gov/show/NCT00409136 Completed Brigham and Women’s Hospital 2008-08-31
NCT00409045 Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00409045 Completed Atlantic Health System NA
NCT00266045 D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence https://ClinicalTrials.gov/show/NCT00266045 Completed St. Orsola Hospital 2008-06-30
NCT00241826 Prospective Investigation of Pulmonary Embolism Diagnosis III https://ClinicalTrials.gov/show/NCT00241826 Completed George Washington University 2008-09-30
NCT00086151 Identifying Low-Risk Patients With Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00086151 Completed National Heart, Lung, and Blood Institute (NHLBI) 2007-06-30
NCT00018772 Risk Factors for Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00018772 Completed VA Office of Research and Development NA
NCT00005504 Epidemiology of Venous Thrombosis and Pulmonary Embolism https://ClinicalTrials.gov/show/NCT00005504 Active, not recruiting University of Minnesota 2030-04-30
NCT00005152 Nurses’ Health Study (Cardiovascular Component) https://ClinicalTrials.gov/show/NCT00005152 Active, not recruiting Brigham and Women’s Hospital 2022-03-31
NCT00005351 Incidence and Outcomes of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT00005351 Completed National Heart, Lung, and Blood Institute (NHLBI) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03185377 Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism in China https://ClinicalTrials.gov/show/NCT03185377 Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital 2020-12-31
NCT03089255 Assessment of the Impact of TIP Score on Thromboprophylaxis in Patients With Non-surgical Lower Leg Trauma. https://ClinicalTrials.gov/show/NCT03089255 Completed University Hospital, Angers 2018-01-15
NCT02943343 The China Pulmonary Thromboembolism Registry Study https://ClinicalTrials.gov/show/NCT02943343 Recruiting China-Japan Friendship Hospital 2019-12-31
NCT02753023 Registry Of Acute meDical Emergencies in Brazil https://ClinicalTrials.gov/show/NCT02753023 Recruiting University of Sao Paulo General Hospital 2019-01-31
NCT02555137 Early Non-invasive Detection of CTEPH After Pulmonary Embolism https://ClinicalTrials.gov/show/NCT02555137 Active, not recruiting Leiden University Medical Center 2019-11-30
NCT02360540 PERCEPIC: PERC Rule Combined With Implicit Low Clinical Probability https://ClinicalTrials.gov/show/NCT02360540 Completed University Hospital, Angers 2016-07-31
NCT02214043 Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population https://ClinicalTrials.gov/show/NCT02214043 Completed Chinese Pulmonary Vascular Disease Research Group 2017-12-31
NCT02155491 Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events https://ClinicalTrials.gov/show/NCT02155491 Active, not recruiting Thrombosis Research Institute 2020-01-04
NCT02032030 Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys https://ClinicalTrials.gov/show/NCT02032030 Active, not recruiting Washington University School of Medicine 2020-07-31
NCT01871194 An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®). https://ClinicalTrials.gov/show/NCT01871194 Completed Drug Safety Research Unit, Southampton, UK 2016-01-31
NCT04414332 Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry https://ClinicalTrials.gov/show/NCT04414332 Completed University of California, Los Angeles 2020-02-27
NCT04355975 Clinical Outcomes After Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT04355975 Recruiting University Hospital Inselspital, Berne 2030-12-31
NCT04122573 Prospective Multicenter Study for Early Evaluation of Acute Chest Pain https://ClinicalTrials.gov/show/NCT04122573 Recruiting West China Hospital 2021-10-31
NCT04037423 European Database on Catheter-directed Treatment of Pulmonary Embolism. https://ClinicalTrials.gov/show/NCT04037423 Recruiting Medical University of Warsaw 2020-12-31
NCT03887819 Pulmonary Embolism: an Autopsy Study https://ClinicalTrials.gov/show/NCT03887819 Completed University of Campania “Luigi Vanvitelli” 2018-06-01
NCT03881345 Ongoing Registry of Treatment of Venous Thromboembolism https://ClinicalTrials.gov/show/NCT03881345 Recruiting Medalp Private Surgery Clinic 2036-03-01
NCT03761173 FlowTriever All-Comer Registry for Patient Safety and Hemodynamics https://ClinicalTrials.gov/show/NCT03761173 Enrolling by invitation Inari Medical 2020-12-31
NCT03660007 Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer https://ClinicalTrials.gov/show/NCT03660007 Completed Karolinska Institutet 2012-12-31
NCT03631810 Contemporary Clinical Management Of Acute Pulmonary Embolism https://ClinicalTrials.gov/show/NCT03631810 Recruiting Heart Care Foundation 2020-12-31
NCT03494556 Prehospital Translation of Chest Pain Tools https://ClinicalTrials.gov/show/NCT03494556 Completed Wake Forest University Health Sciences 2019-02-18
NCT03426124 An International Pulmonary Embolism Registry Using EKOS https://ClinicalTrials.gov/show/NCT03426124 Recruiting EKOS Corporation 2020-06-30
NCT02532387 Outpatient Treatment of PE and DVT in the Emergency Department https://ClinicalTrials.gov/show/NCT02532387 Completed Massachusetts General Hospital 2017-02-28
NCT03916302 Pulmonary Embolism WArsaw REgistry https://ClinicalTrials.gov/show/NCT03916302 Recruiting Medical University of Warsaw 2028-12-31